Cargando…

Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families

We report analyses of a Brazilian study of early onset schizophrenia (BEOS) families. We genotyped 22 members of 4 families on a linkage SNP array and report here non-parametric linkage analyses using MERLIN® software. We found suggestive evidence for linkage on two chromosomal regions, 13q32 and 11...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadelha, Ary, Ota, Vanessa Kiyomi, Cano, Jose Paya, Melaragno, Maria Isabel, Smith, Marilia A. C., de Jesus Mari, Jair, Bressan, Rodrigo A., Belangero, Sintia Iole, Breen, Gerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534097/ https://www.ncbi.nlm.nih.gov/pubmed/23300629 http://dx.doi.org/10.1371/journal.pone.0052262

Ejemplares similares

PRODH Polymorphisms, Cortical Volumes and Thickness in Schizophrenia
por: Ota, Vanessa K., et al.
Publicado: (2014)

Gene expression over the course of schizophrenia: from clinical high-risk for psychosis to chronic stages
por: Ota, Vanessa Kiyomi, et al.
Publicado: (2019)

The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
por: Gouvêa, Eduardo S., et al.
Publicado: (2017)

Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
por: Matsuzaka, Camila T., et al.
Publicado: (2017)

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

T176. REDUCED WHITE MATTER ‘CONNECTIVITY’ IN THE SPLENIUM OF THE CORPUS CALLOSUM IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Assunção-Leme, Idaiane, et al.
Publicado: (2018)

F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA
por: Higuchi, Cinthia, et al.
Publicado: (2018)

Schizophrenia and COVID-19: risks and recommendations
por: Fonseca, Lais, et al.
Publicado: (2020)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
por: Noto, Cristiano, et al.
Publicado: (2015)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?
por: Nani, João V, et al.
Publicado: (2020)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

S24. PATHWAYS LINKING ENVIRONMENTAL RISKS, POLYGENIC RISK SCORE TO SCHIZOPHRENIA AND PSYCHOTIC EXPERIENCES IN A BRAZILIAN COHORT OF CHILDREN AND ADOLESCENTS
por: Fonseca, Lais, et al.
Publicado: (2020)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder
por: de Jong, Simone, et al.
Publicado: (2018)

T117. INVESTIGATION OF FORMAL THOUGHT DISORDER AND RESPONSE TO TREATMENT IN SCHIZOPHRENIA
por: Loures Malinowski, Fernando Rocha, et al.
Publicado: (2018)

S174. POLYENVIRONMENTAL AND POLYGENIC RISK SCORES AND THE EMERGENCE OF PSYCHOTIC EXPERIENCES IN CHILDREN AND ADOLESCENTS
por: Belangero, Sintia, et al.
Publicado: (2020)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

Component mechanisms of executive function in schizophrenia and their contribution to functional outcomes
por: Berberian, Arthur A., et al.
Publicado: (2018)

O1.4. HOW THE MOST CITED RESEARCH ARTICLES ABOUT SCHIZOPHRENIA IN 2018 DEPICT THE DISEASE?
por: Tonsig, Gabriela, et al.
Publicado: (2020)

Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022)

S129. DOES TREATMENT RESISTANT SCHIZOPHRENIA PRESENT A CHARACTERISTIC SYMPTOMATIC SIGNATURE?
por: Bertolucci, Bruno, et al.
Publicado: (2018)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics
por: Nani, João V., et al.
Publicado: (2020)

F91. ASSOCIATION BETWEEN SYMPTOM DIMENSIONS AND EXECUTIVE FUNCTION IN SCHIZOPHRENIA
por: Franco, Ana Luiza, et al.
Publicado: (2018)

Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping
por: Zaharieva, Irina, et al.
Publicado: (2008)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia
por: Pinaya, Walter H. L., et al.
Publicado: (2016)

32. DIGGING DEEPER IN THE PROTEOME OF SCHIZOPHRENIA
por: Martins-De-Souza, Daniel
Publicado: (2018)

The involvement of DARPP-32 in the pathophysiology of schizophrenia
por: Wang, Haitao, et al.
Publicado: (2017)

Is semantic verbal fluency impairment explained by executive function deficits in schizophrenia?
por: Berberian, Arthur A., et al.
Publicado: (2016)

Gene expression changes associated with trajectories of psychopathology in a longitudinal cohort of children and adolescents
por: Ota, Vanessa Kiyomi, et al.
Publicado: (2020)

Diversity matters: opportunities in the study of the genetics of psychotic disorders in low- and middle-income countries in Latin America
por: Fonseca, Lais, et al.
Publicado: (2020)

The relationship between schizophrenia and rheumatoid arthritis revisited: Genetic and epidemiological analyses
por: Euesden, Jack, et al.
Publicado: (2015)

32.3 MAGNIFYING THE PROTEOME OF SCHIZOPHRENIA BRAINS
por: Fioramonte, Mariana, et al.
Publicado: (2018)

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression
por: Warburton, Alix, et al.
Publicado: (2016)

Hair cortisol in drug-naïve first-episode individuals with psychosis
por: Andrade, Elvis H., et al.
Publicado: (2016)

Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137
por: Warburton, Alix, et al.
Publicado: (2015)

Impact of schizophrenia genetic liability on the association between schizophrenia and physical illness: data-linkage study
por: Kendall, Kimberley M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k89k51am1a2bmekif1acavc947